Panacea Biotec has been elected for supply of Pentavalent Vaccine DTP-HepB-Hib by Pan American Health Organization (PAHO). The Company has been awarded for supply of 5.99 Million doses of EasyFive-TT (DTP-HepB-Hib) fully liquid Pentavalent Vaccine for calendar year 2015 & 2016 worth USD 13.49 Million (equivalent to around Rs 83.52 crore) to meet the requirements of global immunization program.
Panacea Biotec is one of India’s leading research based health management companies with established research, manufacturing and marketing capabilities.